- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Anthera Pharmaceuticals Inc+ Add to Watchlist
ANTH:US5.1100 USD 0.1800 3.65%
As of 17:20:00 ET on 05/27/2015.
Company Profile for Anthera Pharmaceuticals Inc (ANTH)
Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.
Anthera Pharmaceuticals Inc
Key Executives for Anthera Pharmaceuticals Inc (ANTH)
|Paul F TruexPresident/CEO/Founder||Debra OdinkSenior VP/CTO|
|Colin HislopSenior VP/Chief Medical Ofcr||Klara A Dickinson-EasonSenior VP/Chief Regulatory Ofcr|
|May LiuSenior VP:Finance & Administration||Paula AdamsVP:Regulatory Affairs|